• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替诺福韦相关性肾毒性在 HIV 感染男性中的不完全可逆性。

Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men.

机构信息

HIV, Immunology, and Infectious Disease Unit and Centre for Applied Medical Research, St. Vincent's Hospital, Sydney, Australia.

出版信息

J Acquir Immune Defic Syndr. 2010 Sep;55(1):78-81. doi: 10.1097/QAI.0b013e3181d05579.

DOI:10.1097/QAI.0b013e3181d05579
PMID:20173649
Abstract

BACKGROUND

Significant nephrotoxicity develops in 1%-2% of HIV-infected adults receiving tenofovir (TDF). This nephrotoxicity is said to resolve rapidly, but this assessment is based on short follow-up, very few patients and use of serum creatinine, an insensitive measure of renal function.

METHODS

We determined the reversibility of TDF-related nephrotoxicity in 24 HIV-infected male outpatients who ceased TDF for renal impairment by retrospective assessment of estimated glomerular filtration rate (eGFR) using the Modified Diet in Renal Disease equation.

RESULTS

Median (interquartile range) eGFR pre-TDF was 74 (61-88) mL.min.1.73 m, fell to 51 (39-61) mL.min.1.73 m at TDF cessation and increased to 58 (48-70) mL.min.1.73 m a median 13 months after TDF cessation (most recent vs pre-TDF eGFR; P = 0.0008). Results were similar with the Cockcroft-Gault equation and after exclusion of patients who had shorter follow-up after TDF cessation. Only 10 (42%) patients reached their pre-TDF eGFR. Greater eGFR improvement was significantly associated with more rapid decline in eGFR on TDF therapy and in those who received TDF with a protease inhibitor, with a trend for shorter duration of TDF therapy.

DISCUSSION

In this population, TDF-related renal toxicity was not always fully reversible.

摘要

背景

接受替诺福韦(TDF)治疗的 1%-2%HIV 感染成年人会出现显著的肾毒性。据称这种肾毒性会迅速缓解,但这种评估基于短期随访、患者数量非常少以及使用血清肌酐,这是一种不敏感的肾功能衡量指标。

方法

我们通过使用改良肾脏病饮食方程(Modified Diet in Renal Disease equation)对 24 名因肾功能损害而停用 TDF 的 HIV 感染男性门诊患者的估算肾小球滤过率(estimated glomerular filtration rate,eGFR)进行回顾性评估,以确定 TDF 相关性肾毒性的可逆性。

结果

TDF 停用前的中位数(四分位距)eGFR 为 74(61-88)mL.min.1.73 m,在 TDF 停用时降至 51(39-61)mL.min.1.73 m,在 TDF 停用后中位数 13 个月时增加至 58(48-70)mL.min.1.73 m(最近 vs 停用 TDF 前的 eGFR;P = 0.0008)。使用 Cockcroft-Gault 方程和排除 TDF 停药后随访时间较短的患者后,结果相似。只有 10 名(42%)患者达到了停用 TDF 前的 eGFR。eGFR 改善更大与 TDF 治疗时 eGFR 更快下降以及接受含蛋白酶抑制剂 TDF 治疗的患者显著相关,TDF 治疗持续时间较短也呈趋势。

讨论

在该人群中,TDF 相关性肾毒性并非总是完全可逆。

相似文献

1
Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men.替诺福韦相关性肾毒性在 HIV 感染男性中的不完全可逆性。
J Acquir Immune Defic Syndr. 2010 Sep;55(1):78-81. doi: 10.1097/QAI.0b013e3181d05579.
2
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure.富马酸替诺福韦二吡呋酯暴露后估计肾小球滤过率下降的不完全可逆性。
J Infect Dis. 2014 Aug 1;210(3):363-73. doi: 10.1093/infdis/jiu107. Epub 2014 Feb 28.
3
Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study.替诺福韦二吡呋酯富马酸丙酚替诺福韦酯加洛匹那韦利托那韦方案对 HIV 感染个体肾功能的影响:一项前瞻性、多中心研究。
BMC Infect Dis. 2013 Jul 1;13:301. doi: 10.1186/1471-2334-13-301.
4
Evaluation of renal adverse effects of combination anti-retroviral therapy including tenofovir in HIV-infected patients.评价包含替诺福韦的联合抗逆转录病毒疗法对 HIV 感染患者的肾脏不良影响。
J Pharm Pharm Sci. 2013;16(3):405-13. doi: 10.18433/j32p5c.
5
Higher risk of renal impairment associated with tenofovir use amongst people living with HIV in India: a comparative cohort analysis between Western India and United Kingdom.在印度,与使用替诺福韦相关的肾功能损害风险较高:印度西部和英国之间的比较队列分析。
BMC Infect Dis. 2014 Mar 29;14:173. doi: 10.1186/1471-2334-14-173.
6
Renal function with use of a tenofovir-containing initial antiretroviral regimen.使用含替诺福韦的初始抗逆转录病毒方案的肾功能。
AIDS. 2009 Sep 24;23(15):1971-5. doi: 10.1097/QAD.0b013e32832c96e9.
7
Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up.长期持续接触替诺福韦会使低体重的HIV-1感染患者的肾功能持续下降:10年随访结果
AIDS. 2014 Aug 24;28(13):1903-10. doi: 10.1097/QAD.0000000000000347.
8
Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).在塞内加尔队列(ANRS 1215)中启动含替诺福韦的抗逆转录病毒治疗后肾功能的变化。
AIDS Res Hum Retroviruses. 2010 Nov;26(11):1221-7. doi: 10.1089/aid.2009.0261. Epub 2010 Sep 21.
9
Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.与基于非核苷类逆转录酶抑制剂的疗法相比,基于蛋白酶抑制剂的疗法使替诺福韦相关肾功能下降更明显。
J Infect Dis. 2008 Jan 1;197(1):102-8. doi: 10.1086/524061.
10
Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial.在接受恩曲他滨替诺福韦二吡呋酯暴露前预防的 HIV-1 未感染男性和女性中肾小球肾脏功能的变化:一项随机临床试验。
JAMA Intern Med. 2015 Feb;175(2):246-54. doi: 10.1001/jamainternmed.2014.6786.

引用本文的文献

1
Tenofovir-Associated Kidney Dysfunction and Bone Fracture: A Case Report and Literature Review.替诺福韦相关的肾功能障碍和骨折:一例报告及文献综述
Cureus. 2024 Jun 3;16(6):e61562. doi: 10.7759/cureus.61562. eCollection 2024 Jun.
2
Tenofovir induced Fanconi syndrome in a middle age African female from Kenya, East Africa: Case report and brief literature review.替诺福韦致一名来自东非肯尼亚的中年非洲女性患范科尼综合征:病例报告及文献简要综述
Clin Case Rep. 2024 May 24;12(6):e8889. doi: 10.1002/ccr3.8889. eCollection 2024 Jun.
3
Prevalence and Risk Factors for Renal Insufficiency among Adults Living with HIV in Tanzania: Results from a Cross-Sectional Study in 2020-2021.
坦桑尼亚成年HIV感染者肾功能不全的患病率及危险因素:2020 - 2021年横断面研究结果
Healthcare (Basel). 2024 Mar 14;12(6):657. doi: 10.3390/healthcare12060657.
4
Changes in Glomerular Filtration Rate After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Fumarate for Human Immunodeficiency Virus Preexposure Prophylaxis.从富马酸替诺福韦二吡呋酯转换为富马酸替诺福韦艾拉酚胺用于人类免疫缺陷病毒暴露前预防后肾小球滤过率的变化
Open Forum Infect Dis. 2023 Dec 29;11(2):ofad695. doi: 10.1093/ofid/ofad695. eCollection 2024 Feb.
5
Updates on HIV and Kidney Disease.人类免疫缺陷病毒与肾脏疾病的最新进展
Curr HIV/AIDS Rep. 2023 Apr;20(2):100-110. doi: 10.1007/s11904-023-00645-1. Epub 2023 Jan 25.
6
HIV, drugs and the kidney.艾滋病病毒、药物与肾脏
Drugs Context. 2020 Mar 10;9. doi: 10.7573/dic.2019-11-1. eCollection 2020.
7
Changes in kidney function among men having sex with men starting on demand tenofovir disoproxil fumarate - emtricitabine for HIV pre-exposure prophylaxis.开始按需服用替诺福韦二吡呋酯-恩曲他滨用于 HIV 暴露前预防的男男性行为者的肾功能变化。
J Int AIDS Soc. 2020 Feb;23(2):e25420. doi: 10.1002/jia2.25420.
8
Kidney Disease in HIV Infection.HIV感染中的肾脏疾病
J Clin Med. 2019 Aug 19;8(8):1254. doi: 10.3390/jcm8081254.
9
Reversal of tenofovir induced nephrotoxicity: case reports of two patients.替诺福韦所致肾毒性的逆转:两例患者的病例报告
Pan Afr Med J. 2017 Jun 16;27:126. doi: 10.11604/pamj.2017.27.126.10033. eCollection 2017.
10
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients.优化在病毒学抑制的HIV感染患者中选择安全的洛匹那韦/利托那韦或达芦那韦/利托那韦单药治疗候选者的标准。
PLoS One. 2017 Feb 13;12(2):e0171611. doi: 10.1371/journal.pone.0171611. eCollection 2017.